DeepScribe Review 2026: Features, Pricing & Verdict

What is DeepScribe?

DeepScribe is an ambient AI medical scribe: software that listens to the natural conversation between a clinician and a patient during a visit, converts it into a structured clinical note, and delivers that note into the electronic health record for the clinician to review and sign. The workflow the vendor describes is deliberately simple. The clinician opens the DeepScribe app at the start of a visit and selects the patient from a synced schedule; the ambient AI records and analyzes the conversation in real time; and when the encounter ends, DeepScribe produces a structured note and syncs it to the EHR in seconds, where the clinician reviews it and signs off. No dictation, no typing during the visit, no copy-and-paste at the end of the day.

What distinguishes DeepScribe within the crowded field of healthcare AI agents is its explicit focus on specialty care. Where many ambient scribes were built first for primary care and then stretched toward specialties, DeepScribe markets itself as "built for specialty medicine," with dedicated positioning, terminology handling and workflows for oncology, cardiology, gastroenterology, neurology, orthopedics and urology, plus a value-based-care track. Oncology is the flagship: the company describes itself as the leading ambient system for cancer care and reports capturing five million oncology visits per year (DeepScribe, 2026). That specialty framing matters because complex, longitudinal specialties are precisely where generic scribes struggle — visits reference months of prior treatment, labs, imaging and staging, and a note that misses that context is not a time-saver but a liability.

Around the core scribe, DeepScribe has assembled what it calls an "ambient operating system": SmartPrep for pre-visit preparation, AI Coding for E/M, ICD-10 and HCC capture, a Customization Studio that adapts notes to each clinician's personal style, and DeepScribe Assist, which surfaces insights at the point of care for quality and value-based-care goals. The pitch to a health-system buyer is therefore broader than documentation relief: it is an ambient layer that prepares the clinician before the visit, documents during it, and codes and delivers data after it.

Where DeepScribe fits in the 2026 ambient documentation market

Ambient clinical documentation has moved from pilot novelty to mainstream infrastructure. By 2026, the question for most health systems is no longer whether to deploy an AI scribe but which one, and the market has stratified: Microsoft's Nuance DAX and Abridge compete for large Epic-standardized enterprises; Nabla and Suki court clinics and groups that want fast, lightweight deployment; Epic itself has announced a native scribe; and DeepScribe has staked out specialty depth — above all oncology — as its defensible ground. For a buyer, that segmentation is the single most useful fact in the category: the "best" scribe depends heavily on your EHR, your specialty mix and your deployment model, which is why our healthcare AI agents hub and the Abridge vs Nabla comparison are worth reading alongside this review.

DeepScribe pricing in 2026

DeepScribe does not publish pricing. There is no price page, no self-serve checkout and no free tier on deepscribe.ai; every path leads to a demo request and a scoped conversation with sales. That is normal for enterprise clinical software, but it means budget planning starts with a quote, not a rate card, and we will not invent dollar figures where the vendor publishes none.

The most useful primary-source signal comes from DeepScribe's own published buyer guidance, which states that pricing in this category "varies by deployment size, feature set, and support model," that health systems "often negotiate enterprise agreements," and that smaller practices "may opt for per-provider subscriptions that are often a few hundred dollars per month" (DeepScribe, 2026). Read that as the vendor's own framing of the market it sells into: per-provider subscription economics at the small end, negotiated enterprise agreements at the top, with the final number shaped by which modules you take (scribe only, or scribe plus SmartPrep, AI Coding and Assist), your EHR integration, and the rollout support involved.

DeepScribe does not disclose list pricing; the table reflects the vendor's own published framing and is directional, not a quote. Get a written proposal scoped to your provider count, modules and EHR before budgeting.

Two practical notes for procurement. First, evaluate cost per clinician-hour recovered rather than sticker price: an ambient scribe that a clinician actually uses every day competes with human scribe services and with after-hours charting time, and that is the honest comparison set. Second, ask explicitly how the coding modules are priced and measured — if part of the pitch is more complete E/M, ICD-10 and HCC capture, the contract discussion should cover how that uplift will be validated in your own billing data, not just asserted.

Detailed feature review

The ambient AI medical scribe

The core product does what the category promises, with a few emphases worth noting. DeepScribe describes its speech recognition as its most advanced models capturing the natural clinician–patient conversation "with extreme accuracy," producing a structured note that syncs directly into the appropriate fields of the EHR rather than into a text blob the clinician must redistribute (DeepScribe, 2026). It works face-to-face and in telehealth visits, and the vendor states it supports patient conversations in more than 110 languages — a genuinely relevant capability for systems serving multilingual populations, and one worth testing with your own patient mix during a pilot.

The differentiating claim, though, is context awareness. DeepScribe says it pulls forward the full scope of the patient's care journey — past notes, labs, imaging, medications, diagnoses — and adapts that history to the current day's note. In longitudinal specialties this is the difference between a note that reads like a transcript and one that reads like clinical documentation: an oncology follow-up note needs the interval history since the last cycle, not just what was said in the room. DeepScribe also markets automated interval-history documentation specifically for oncologists. Buyers should probe this hard in evaluation, because context-aware drafting is both the highest-value and hardest-to-do-well part of ambient documentation; ask to see it working against your own EHR data, not a demo chart.

SmartPrep: pre-visit intelligence

SmartPrep, which DeepScribe introduced for oncology, synthesizes the relevant documents in a patient's chart before the visit and surfaces only what matters for today's encounter. The problem it targets is real and expensive: in complex care, clinicians spend substantial time "pre-charting" — digging through prior notes, labs and imaging to reconstruct where the patient is in their journey — before they ever open the exam-room door. A pre-visit summary that is actually trustworthy shortens that ritual and changes the shape of the visit. As with any AI summarization of clinical records, the evaluation question is reliability: what does it include, what does it omit, and how quickly can a clinician verify a surfaced fact against the source document. Treat SmartPrep as a supervised assist, and test it on your messiest charts.

AI Coding: E/M, ICD-10 and HCC

DeepScribe's coding module is a meaningful part of its enterprise pitch, and it is more built-out than many rivals': dedicated support for E/M level selection, ICD-10 diagnosis capture and HCC risk-adjustment coding, with what the vendor describes as real-time insights and audit-ready documentation. The strategic logic is straightforward. Documentation and coding are the same conversation viewed by two departments; if the ambient system already understands the encounter, it can propose the codes the encounter supports. For value-based-care organizations, HCC capture in particular ties directly to risk-adjusted revenue, which is why DeepScribe leads with it in its value-based-care positioning. The vendor also reports a 34% increase in ICD-10 codes generated among its users (DeepScribe, 2026) — a vendor-reported figure we have not independently verified, and one any buyer should replicate on their own claims data during a pilot. The compliance corollary matters equally: coding suggestions must support what was actually documented and done, so deploy this with your compliance team in the room, not after the fact.

Customization Studio

Clinician adoption is where ambient scribes live or die, and note style is a surprisingly large part of it. Clinicians reject notes that are accurate but alien — wrong structure, wrong phrasing, wrong level of detail. DeepScribe's Customization Studio addresses this by learning each clinician's documentation style and voice, evolving with feedback, and exposing granular controls: the vendor's own examples include adding names to a proper-noun dictionary, formatting a social history as a numbered list, and organizing the HPI by problem with specific heading styles. Per-clinician customization at that granularity, applied out of the box and refined over time, is a credible answer to the "every doctor documents differently" problem, and it is a fair question to put to any competing vendor in a bake-off.

DeepScribe Assist and Diagnosis Intelligence

Two further layers round out the platform. DeepScribe Assist surfaces key insights at the point of care to support health systems' quality and value-based goals — the vendor's step beyond documentation into clinical-workflow support. Diagnosis Intelligence surfaces potential diagnoses from the conversation, which DeepScribe frames as reducing oversights and helping document the full clinical picture. Both are the kind of features that should be governed like clinical decision support: useful when they prompt a clinician to document something real that would otherwise be missed, risky if they nudge documentation beyond what the encounter supports. A disciplined deployment defines who sees these prompts and how their impact is audited.

EHR integrations

DeepScribe advertises bi-directional sync with "enterprise-wide EHRs and specialty-specific platforms," and its integration story leans specialty like everything else about the product. The integrations page features Epic alongside two oncology-specific systems, iKnowMed Generation 2 and OncoEMR (DeepScribe, 2026) — a telling trio, since the oncology EHRs are exactly what a generalist scribe vendor would not prioritize. DeepScribe's published comparison material additionally lists athenahealth, DrChrono, eClinicalWorks, UroChart, ModMed and Objective Medical Systems among supported EHRs, with the site inviting practices on other systems to ask about options.

The functional claims are the right ones: notes sync into the appropriate EHR fields with no copy-paste, the schedule syncs into the app, codes are generated into the workflow, and prior-chart data is pulled forward for context. As with every EHR integration claim in this market, depth varies by system and version — "integrates with Epic" can mean anything from deep embedded workflow to a sanctioned side panel — so the evaluation step is non-negotiable: have the vendor demonstrate the integration on your EHR, your version, your note types and your order workflows, and talk to a reference site on the same stack. DeepScribe also lists technical partners including AWS, Anthropic, Deloitte and Panda Health on its integrations page, which offers some signal about its underlying infrastructure and AI supply chain.

Security, HIPAA and compliance posture

Because an ambient scribe records clinical conversations and touches the chart, its security posture is a first-order buying criterion, not a checkbox. Here is what DeepScribe states publicly, which we relay as vendor claims for your diligence rather than as our own audit. The company displays SOC 2 and HIPAA attestations on its homepage and states that its ambient operating system is "100% HIPAA compliant." Its integrations page details end-to-end AES-256 encryption of captured and processed data, de-identification that strips personal identifiers from encrypted data, multi-factor authentication, limited user-access permissions on both the customer's side and DeepScribe's, and single sign-on support (DeepScribe, 2026). The company also maintains a public trust center at trust.deepscribe.ai where security documentation can be requested.

Procurement should still do the standard PHI-vendor work: execute a business associate agreement, obtain the SOC 2 report rather than the badge, ask precisely how audio and transcripts are retained and for how long, whether and how customer data is used to train or tune models, what the de-identification pipeline actually covers, and how patient consent should be handled in your states of operation. On consent, DeepScribe's own guidance is that organizations should follow site-specific consent policies and state law, typically informing patients that an AI scribe is assisting documentation — sensible framing, but the legal obligation sits with the provider organization, and two-party-consent states deserve specific counsel review.

Vendor-reported outcomes and the KLAS score

DeepScribe publishes a set of outcome figures that recur throughout its marketing: 2.2 hours saved daily per clinician, 34% more ICD-10 codes generated, 1.6-minute chart closure time, and 85% clinician adoption (DeepScribe, 2026). It also promotes its performance in a KLAS Spotlight report, citing an overall performance score of 98.8 out of 100 (DeepScribe/KLAS, 2025), which the vendor describes as the highest in the category at the time of publication.

How to weigh this: KLAS is a genuinely independent healthcare-IT research firm whose scores are based on interviews with provider organizations, so a strong Spotlight score is meaningful evidence of customer satisfaction — but Spotlight reports examine one vendor at a time with that vendor's customers, scores are published from different years across competitors, and a 98.8 versus a 95.3 does not settle a head-to-head for your organization. The per-clinician outcome figures are vendor-reported aggregates; we have not verified them, and your mileage will depend on specialty, EHR and rollout quality. The right use of all these numbers is as pilot hypotheses: measure time-to-note-closure, after-hours charting, coding capture and adoption in your own 60–90 day pilot, and let your data decide.

Who should use DeepScribe — and who should skip it

Use it if you are a specialty practice or health system in complex, longitudinal care — oncology first and foremost, but also cardiology, urology, orthopedics, neurology or gastroenterology — where context-aware notes, interval histories and specialty terminology are the whole game. Oncology groups on iKnowMed or OncoEMR are squarely in DeepScribe's sweet spot, as are value-based-care organizations that want HCC and E/M capture built into the documentation layer rather than bolted on afterward, and multilingual practices that will actually exercise the 110-plus-language support.

Skip it, or at least shortlist it against alternatives, if you are a generalist primary-care group whose needs are well served by lighter, faster-to-deploy scribes — Nabla in particular courts that buyer — or a large Epic-standardized system already deep in negotiations with Abridge or Nuance DAX, where ecosystem alignment may outweigh specialty depth. Solo practitioners on unsupported EHRs should confirm integration options before falling for the demo, and any organization that requires published, self-serve pricing to even begin a procurement conversation will not find it here.

Implementation notes

Ambient scribes look like app installs and behave like change-management programs. A realistic DeepScribe deployment plan has four parts. First, integration: stand up the bi-directional EHR connection, confirm schedule sync, note-field mapping and code delivery on your actual system, and decide which note types and visit types are in scope. Second, pilot: pick a defined cohort — one specialty, one clinic — and baseline the metrics you care about before turning anything on: note-closure time, after-hours EHR time, coding capture, clinician-reported burden. Third, customization and training: the Customization Studio rewards early investment, so budget time in the first weeks for clinicians to shape their note formats and feed back corrections rather than silently editing output; that feedback loop is what converts a good demo into a note the clinician stops re-writing. Fourth, governance: involve compliance in coding-suggestion workflows, settle consent scripting and signage per state law, define who audits a sample of AI-drafted notes and how often, and document your review-and-sign policy so it is unambiguous that clinicians own the record.

Timelines vary with EHR and scale — a small practice on a supported EHR can be live in days, while an enterprise Epic deployment is a scoped project with IT security review, SSO configuration and phased rollout. The vendor's own positioning emphasizes structured enterprise rollouts with governance, analytics and hands-on support; make that support model an explicit part of the contract, because at-the-elbow help in week one is a measurable driver of whether adoption lands near the vendor's reported 85% or well below it.

Total cost of ownership and ROI

The honest ROI frame for an ambient scribe is clinician time and documentation quality against subscription, implementation and governance cost. On the cost side, count the per-provider or enterprise fee, EHR-integration and IT-security effort, training time, and the ongoing cost of compliance oversight for coding suggestions. On the return side, the candidate benefits are after-hours charting reclaimed, faster chart closure, more complete coding capture (with revenue implications in both fee-for-service and risk-adjusted models), reduced use of human scribe services, and the softer but real effects on clinician retention and burnout — in a market where replacing a single physician is enormously expensive, a documentation tool that clinicians credit with getting their evenings back is not a rounding error. The discipline is to measure rather than assume: baseline before the pilot, measure at 60–90 days, and hold the vendor's reported figures — 2.2 hours saved daily, 34% more ICD-10 codes — to the standard of your own data. Organizations that skip the baseline never actually learn what they bought.

How DeepScribe compares to the alternatives

The ambient-scribe field is crowded, and the practical comparison set for most DeepScribe buyers is short. Abridge is the enterprise heavyweight: strong momentum in large health systems, structured real-time notes, and a historically close Epic alignment that makes it a default candidate for Epic-standardized enterprises, particularly in primary care and templated specialties. Nabla attacks from the opposite end — lightweight, flexible deployment across web, mobile, browser extension and API, multilingual support and fast time-to-value for clinics and digital-health teams that want a documentation layer without an enterprise program. Microsoft's Nuance DAX remains the incumbent at scale with deep Epic integration and decades of speech heritage, and Epic's own announced native scribe looms over the whole category for Epic shops.

DeepScribe's claim against all of them is specialty depth: oncology-grade context awareness, specialty EHR integrations like iKnowMed and OncoEMR that rivals do not lead with, built-in E/M, ICD-10 and HCC coding, and per-clinician customization. For a cancer center or specialty group, that positioning is genuinely differentiated. For a generalist group, the decision is closer and should be tested head-to-head — our Abridge vs Nabla comparison walks through the two most common alternatives in detail, and the healthcare AI agents hub maps the wider field. Whatever the shortlist, run the same pilot protocol on each candidate: same clinics, same metrics, same charts.

How we scored DeepScribe

Our 8.4/10 is a weighted editorial assessment across the six dimensions in the scorecard below, per our methodology. DeepScribe scores highest on features and specialty depth — the SmartPrep, coding and customization layers are ahead of much of the field — and on integrations within its target specialties. It scores lower on pricing transparency, since there is no public rate card and every engagement is quote-scoped, and we discount vendor-reported outcome figures that we cannot independently verify. We attach no user-review rating; we publish aggregate user scores only when enough verified practitioner submissions exist for an agent, and until then the only user-input surface on this page is the experience form below.

Verdict

DeepScribe is one of the most convincing specialty-first ambient documentation platforms on the market in 2026. Its strengths are exactly where complex medicine hurts most: context pulled forward from the longitudinal record, pre-visit synthesis, coding intelligence that speaks E/M, ICD-10 and HCC, per-clinician note customization, and integrations that include the oncology EHRs generalist vendors ignore. The honest caveats: pricing is quote-only, the most-quoted outcome numbers are vendor-reported until you replicate them, and — as with every PHI-touching AI vendor — the compliance diligence is yours to do, not to outsource to a badge wall. For oncology and complex specialty buyers, DeepScribe belongs at the top of the shortlist and earns its 8.4/10. Generalist primary-care groups should run it against Abridge and Nabla and let a measured pilot pick the winner.

Editorial scorecard

Pros and cons

Alternatives to DeepScribe

Frequently Asked Questions